Skip to Content

M L53 (Lamotrigine 150 mg)

Pill imprint M L53 has been identified as Lamotrigine 150 mg.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; borderline personality disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamotrigine 150 mg M L53
Lamotrigine 150 mg M L53
Discount Card Promo
Lamotrigine
Imprint:
M L53
Strength:
150 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4253
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0865 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide